Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

NCT01611272 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01611272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
July 20, 2016
Enrollment
3,402 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes